Related Experiment Video
Updated: Sep 4, 2025

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Hemodynamic stress-induced cardiac remodelling is not modulated by ablation of phosphodiesterase 4D interacting
Belal A Mohamed1,2, Manar Elkenani1,2, Sherok Mobarak1
1Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany.
Insights
Phosphodiesterase 4D interacting protein (Pde4dip) deficiency did not alter adverse cardiac remodeling in mice subjected to hemodynamic overload. Pde4dip does not appear to be a key factor in heart adaptation to stress.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Adrenergic stimulation activates protein kinase A (PKA) in the heart, influencing intracellular calcium handling.
- A kinase anchoring proteins (AKAPs), like phosphodiesterase 4D interacting protein (Pde4dp), scaffold PKA to its substrates.
- Pde4dip expression changes with hemodynamic overload, a condition causing cardiac stress.
Purpose of the Study:
- To investigate the role of Pde4dp in adverse cardiac remodeling following hemodynamic stress.
- To determine if Pde4dp deficiency impacts cardiac structure, function, and pathology after volume or pressure overload.
Main Methods:
- Generated homozygous Pde4dip knockout (KO) mice using CRISPR-Cas9 technology.
- Subjected KO and wild-type (WT) mice to aortocaval shunt (volume overload) or transthoracic aortic constriction (pressure overload).
- Assessed mortality, cardiac structure, function, and pathological remodeling post-injury.
Main Results:
- Pde4dp protein levels were differentially regulated in WT hearts under volume (downregulated) versus pressure (upregulated) overload.
- Mortality rates were similar between Pde4dp-KO and WT mice following both shunt and TAC procedures.
- Cardiac hypertrophy, dilatation, dysfunction, cardiomyocyte hypertrophy, fibrosis, and gene expression changes did not differ between genotypes after hemodynamic stress.
Conclusions:
- Despite altered Pde4dp protein expression in stressed hearts, Pde4dp deficiency does not influence adverse cardiac remodeling in response to hemodynamic volume or pressure overload.
- Pde4dp is not a critical mediator of cardiac adaptation or maladaptation to significant hemodynamic stress.
Abstract:
Adrenergic stimulation in the heart activates the protein kinase A (PKA), which phosphorylates key proteins involved in intracellular Ca2+ handling. PKA is held in proximity to its substrates by protein scaffolds, the A kinase anchoring proteins (AKAPs). We have previously identified the transcript of phosphodiesterase 4D interacting protein (Pde4dip; also known as myomegalin), one of the sarcomeric AKAPs, as being differentially expressed following hemodynamic overload, a condition inducing hyperadrenergic state in the heart. Here, we addressed whether PDE4DIP is involved in the adverse cardiac remodelling following hemodynamic stress. Homozygous Pde4dip knockout (KO) mice, generated by CRISPR-Cas9 technology, and wild-type (WT) littermates were exposed to aortocaval shunt (shunt) or transthoracic aortic constriction (TAC) to induce hemodynamic volume overload (VO) or pressure overload (PO), respectively. The mortality, cardiac structure, function and pathological cardiac remodelling were followed up after hemodynamic injuries. The PDE4DIP protein level was markedly downregulated in volume-overloaded- but upregulated in pressure-overloaded-WT hearts. Following shunt or TAC, mortality rates were comparably increased in both genotypes. Twelve weeks after shunt or TAC, Pde4dip-KO animals showed a similar degree of cardiac hypertrophy, dilatation and dysfunction as WT mice. Cardiomyocyte hypertrophy, myocardial fibrosis, reactivation of cardiac stress genes and downregulation of ATPase, Ca2+ transporting, cardiac muscle, slow twitch 2 transcript did not differ between WT and Pde4dip-KO hearts following shunt or TAC. In summary, despite a differential expression of PDE4DIP protein in remodelled WT hearts, Pde4dip deficiency does not modulate adverse cardiac remodelling after hemodynamic VO or PO.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy III: Hypertrophic Cardiomyopathy

